Naltrexone Completed Phase 3 Trials for BMI >27 kg/m2 / Type 2 Diabetes Mellitus / BMI >30 kg/m2 Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00474630A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes